Home › Trial NCT00062127
Irinotecan and Thalidomide in Treating Patients With Advanced Solid Tumors
- Trial IDNCT00062127
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorNational Cancer Institute (NCI)
- Enrollment35
- Start date2003-04
- ConditionsUnspecified Adult Solid Tumor, Protocol Specific
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.